190 related articles for article (PubMed ID: 160589)
1. Effects of PGI2 on the inactivation of thrombin, factor Xa, and plasmin by antithrombin-III and heparin.
Blaskó G
Prostaglandins; 1979 Jul; 18(1):3-9. PubMed ID: 160589
[TBL] [Abstract][Full Text] [Related]
2. Role of heparin in the inactivation of thrombin, factor Xa, and plasmin by antithrombin III.
Stürzebecher J; Markwardt F
Thromb Res; 1977 Dec; 11(6):835-46. PubMed ID: 146278
[No Abstract] [Full Text] [Related]
3. Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.
Cerskus AL; Birchall KJ; Ofosu FA; Hirsh J; Blajchman MA
Can J Biochem Cell Biol; 1984 Oct; 62(10):975-83. PubMed ID: 6509363
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulant activity of artificial biomedical materials with co-immobilized antithrombin III and heparin.
Miura Y; Aoyagi S; Ikeda F; Miyamoto K
Biochimie; 1980; 62(8-9):595-601. PubMed ID: 7417594
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation and inactivation in the presence of antithrombin III and heparin.
Lindhout T; Baruch D; Schoen P; Franssen J; Hemker HC
Biochemistry; 1986 Oct; 25(20):5962-9. PubMed ID: 3790498
[TBL] [Abstract][Full Text] [Related]
7. The characteristics of anticoagulation by covalently immobilized heparin.
Miura Y; Aoyagi S; Kusada Y; Miyamoto K
J Biomed Mater Res; 1980 Sep; 14(5):619-30. PubMed ID: 7349668
[TBL] [Abstract][Full Text] [Related]
8. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.
Jordan RE; Oosta GM; Gardner WT; Rosenberg RD
J Biol Chem; 1980 Nov; 255(21):10081-90. PubMed ID: 6448846
[TBL] [Abstract][Full Text] [Related]
9. GAGs-potentiated inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III - correlation with total charge density.
Cofrancesco E; Vigo A; Pogliani EM
Thromb Haemost; 1981 Dec; 46(4):749-51. PubMed ID: 6460339
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.
MacGregor IR; Lane DA; Kakkar VV
Biochim Biophys Acta; 1979 Sep; 586(3):584-93. PubMed ID: 476156
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III.
Baruch D; Lindhout T; Wagenvoord R; Hemker HC
Haemostasis; 1986; 16(2):71-81. PubMed ID: 3086193
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of thrombin and plasmin to heparin and antithrombin III.
Bauer PI; Breuer Z; Machovich R; Büki KG; Horváth I
Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):155-61. PubMed ID: 2944348
[TBL] [Abstract][Full Text] [Related]
13. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
Tran TH; Bondeli C; Marbet GA; Duckert F
Thromb Haemost; 1980 Oct; 44(2):92-5. PubMed ID: 7455997
[TBL] [Abstract][Full Text] [Related]
14. Interaction of heparin with lipoproteins - role of the complex in the inactivation of thrombin and plasmin.
Kecskés E; Büki KG; Bauer PI; Machovich R; Horváth I
Thromb Haemost; 1983 Apr; 49(2):138-41. PubMed ID: 6223404
[TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis of the heparin-enhanced plasmin--antithrombin III reaction. Apparent catalytic role of heparin.
Machovich R; Bauer PI; Arányi P; Kecskés E; Büki KG; Horváth I
Biochem J; 1981 Dec; 199(3):521-6. PubMed ID: 6462134
[TBL] [Abstract][Full Text] [Related]
16. Heparin and protease inhibition. II. The role of heparin in the ATIII inactivation of thrombin, plasmin, and trypsin.
Smith GF; Sundboom JL
Thromb Res; 1981 Apr 1-15; 22(1-2):115-33. PubMed ID: 6457414
[No Abstract] [Full Text] [Related]
17. The effect of a sulfated polysaccharide on antithrombin III.
Czapek EE; Kwaan HC; Szczecinski M
J Lab Clin Med; 1980 Jun; 95(6):783-90. PubMed ID: 6155418
[TBL] [Abstract][Full Text] [Related]
18. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
[TBL] [Abstract][Full Text] [Related]
19. Protection of factor Xa from neutralization by the heparin-antithrombin complex.
Teitel JM; Rosenberg RD
J Clin Invest; 1983 May; 71(5):1383-91. PubMed ID: 6222069
[TBL] [Abstract][Full Text] [Related]
20. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
Scully MF; Kakkar VV
Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
